M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 54.32 USD 4.74% Market Closed
Market Cap: 3.5B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

Income Statement

Earnings Waterfall
MoonLake Immunotherapeutics

Revenue
0 USD
Operating Expenses
-108.5m USD
Operating Income
-108.5m USD
Other Expenses
27.8m USD
Net Income
-80.8m USD

Income Statement
MoonLake Immunotherapeutics

Rotate your device to view
Income Statement
Currency: USD
Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(69)
(54)
(63)
(65)
(62)
(58)
(56)
(54)
(61)
(78)
(109)
Selling, General & Administrative
(23)
(27)
(27)
(23)
(23)
(21)
(21)
(22)
(24)
(26)
(28)
Research & Development
(46)
(27)
(36)
(42)
(39)
(37)
(35)
(32)
(37)
(52)
(81)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
Operating Income
(69)
N/A
(54)
+22%
(63)
-16%
(65)
-4%
(62)
+5%
(58)
+7%
(56)
+3%
(54)
+3%
(61)
-13%
(78)
-28%
(109)
-38%
Pre-Tax Income
Total Other Income
0
0
0
1
1
2
3
10
15
20
26
Pre-Tax Income
(69)
N/A
(54)
+22%
(62)
-16%
(64)
-3%
(61)
+6%
(56)
+8%
(53)
+6%
(44)
+16%
(46)
-4%
(58)
-27%
(82)
-42%
Net Income
Tax Provision
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Income from Continuing Operations
(69)
(54)
(62)
(65)
(61)
(56)
(53)
(44)
(46)
(58)
(83)
Income to Minority Interest
0
0
0
15
18
20
22
8
5
3
2
Net Income (Common)
(69)
N/A
(54)
+22%
(62)
-16%
(50)
+20%
(43)
+14%
(36)
+17%
(31)
+15%
(36)
-18%
(41)
-13%
(55)
-35%
(81)
-47%
EPS (Diluted)
-2.49
N/A
-1.53
+39%
-1.68
-10%
-1.7
-1%
-1.1
+35%
-0.81
+26%
-0.57
+30%
-0.73
-28%
-0.64
+12%
-0.87
-36%
-1.29
-48%

See Also

Discover More